Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition: Rhinitis, Allergic Interventions: Drug: Mometasone furoate nasal spray (MFNS); Drug: Loratadine; Drug: Placebo nasal spray; Drug: Placebo tablet Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition: Rhinitis, Allergic Interventions: Drug: Mometasone furoate nasal spray (MFNS); Drug: Loratadine; Drug: Placebo nasal spray; Drug: Placebo tablet Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition: Rhinitis, Allergic Interventions: Drug: Mometasone furoate nasal spray (MFNS); Drug: Loratadine; Drug: Placebo nasal spray; Drug: Placebo tablet Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)
Condition: Rhinitis, Allergic Interventions: Drug: Mometasone furoate nasal spray (MFNS); Drug: Loratadine; Drug: Placebo nasal spray; Drug: Placebo tablet Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)
Condition: Seasonal Allergic Rhinitis Interventions: Drug: Mometasone Furoate (MF); Drug: Beclomethasone Dipropionate (BDP); Drug: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials
Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
Condition: Sickle Cell Disease Interventions: Drug: Placebo; Drug: Mometasone Sponsors: Jeffrey Glassberg; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2018 Category: Research Source Type: clinical trials